
Precision Medicine Market Global Forecast Report by Product (Consumables, Instruments, Services) Technology (Big Data Analytics, Bioinformatic, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others) Application (Oncology, Central Nervous System (
Description
Precision Medicine Market Global Forecast Report by Product (Consumables, Instruments, Services) Technology (Big Data Analytics, Bioinformatic, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others) Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, Others) End User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, Others) Countries and Company Analysis, 2024-2032
Trauma Fixation Device Market Analysis
The global market for trauma fixation devices was US$ 8.13 billion in 2023 and is projected to reach US$ 13.95 billion by 2032. This represents a growth rate of 6.19% from 2024 to 2032. The market is expected to grow over the forecast period due to the increasing elderly population worldwide, higher incidence of osteoporosis and other bone diseases among the elderly, a rise in accidents and burn injuries, and an increase in disposable income.
Trauma Fixation Device Market Overview
Trauma fixation devices play a crucial role in medical treatment by providing implants and instruments to stabilize and promote the healing of fractures and broken bones. This medical equipment is vital for addressing bone fractures and tissue degeneration. Trauma fixation devices are among the earliest medical devices and are still widely used in modern healthcare.
Trauma fixation devices, such as plates, screws, rods, pins, and external fixators, are used for internal fixation. They are surgically implanted directly into the bone or adjacent soft tissues to provide structural stability, facilitate bone healing, and restore normal anatomical alignment. These devices help to reduce hospital stays, enable patients to return to function earlier, and decrease the incidence of nonunion (improper healing) and malunion (healing in an inappropriate position) of broken bones.
Growth Drivers in the Trauma Fixation Devices Market
Rising Incidence of Road Accidents and Trauma Cases
The increasing number of road accidents and trauma-related injuries globally is driving the trauma fixation devices market. Urbanization and rising traffic density have led to more frequent road mishaps, resulting in a surge in bone fractures and other serious injuries. This has created a growing demand for trauma fixation devices like plates, screws, and intramedullary nails. Falls, particularly among older people, have also become a significant concern. These factors increase the need for effective and quick recovery solutions, increasing demand for external and internal fixation devices. Road traffic injuries are the leading cause of fatality in children and young adults, with 20-50 million people suffering from non-fatal injuries in road accidents resulting in disability each year.
Advancements in Technology and Product Innovation
Technological advancements and continuous product innovation are driving the trauma fixation devices market. Manufacturers focus on developing devices with enhanced biocompatibility, durability, and ease of use to improve patient outcomes. Innovations such as bioabsorbable and smart implants integrated with sensors reduce the need for secondary surgeries and gain traction. These advancements improve trauma fixation effectiveness and cater to the growing demand for minimally invasive procedures. In June 2023, Invibio Biomaterial Solutions and Paragon Medical announced a collaboration to manufacture composite PEEK-OPTIMA™ Ultra-Reinforced medical trauma devices.
Growing Geriatric Population and Osteoporosis Cases
The trauma fixation devices market is witnessing growth due to the increasing prevalence of osteoporosis and related fractures among the elderly population. The rising senior population globally is leading to a surge in age-related bone conditions, resulting in a higher demand for effective fixation solutions. Healthcare providers are emphasizing better treatment options and fracture management in elderly patients. The WHO predicts that the elderly population will reach 12 billion by 2025, and as of 2024, 10.3% of the global population is 65 and older, according to UNFPA data.
North American Trauma Fixation Device Market Overview
The trauma fixation devices market in North America is expected to grow significantly due to factors such as the prevalence of trauma-related brain injuries, ongoing product development activities by regulatory authorities, and well-established healthcare facilities. The region's robust healthcare infrastructure and the presence of key market players are also contributing to this growth. In 2021, there were over 586 traumatic brain injury-related hospitalizations per day in the US. These injuries require prompt diagnosis for assessment and treatment decisions.
Orthopedic surgery for children and adolescents can now use OSSIOfiber® bio-integrative fixation technology after being cleared by the FDA in December 2023. This technology allows the use of OSSIOfiber Compression Screws and Trimmable Fixation Nails in children aged two to 21 years. Key players like DePuy Synthes, Stryker Corporation, and Zimmer Biomet are contributing to the growth of the regional trauma fixation devices market through their strong distribution networks.
Trauma Fixation Device Market Company Overview
Some industry leaders in the Global Trauma Fixation Device Market include Zimmer Biomet, Orthofix Medical Inc, B. Braun Melsungen AG, Stryker, Medtronic, Smith & Nephew, and Integra LifeSciences.
Trauma Fixation Device Market News
In October 2023, Johnson & Johnson obtained FDA approval for the TriALTIS spine system and TriALTIS navigation-enabled instruments, which are next-generation posterior thoracolumbar pedicle screw systems and associated instrumentation.
In September 2023, Orthofix Medical Inc. launched the Galaxy Fixation Gemini system in the U.S. It is an external fixation device for repairing fractures in the lower and upper limbs caused by trauma.
Products – Market breakup in 3 viewpoints:
1. External Fixators
2. Internal Fixators
3. Others
Material – Market breakup in 3 viewpoints:
1. Stainless Steel
2. Titanium
3. Others
End User – Market breakup in 3 viewpoints:
1. Hospitals
2. Special Clinics
3. Ambulatory Surgery Centers
Country – Market breakup in 26 viewpoints:
North America
United States
Canada
Europe
France
Germany
Italy
Spain
United Kingdom
Belgium
the Netherlands
Turkey
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Malaysia
Indonesia
New Zealand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
United Arab Emirates
Rest of the World
All the Key players have been covered from 5 Viewpoints:
• Overviews
• Key Person
• Recent Developments & Strategies
• Product Portfolio & Product Launch in Last 1 Year
• Revenue
Company Analysis:
1. Zimmer Biomet
2. Orthofix Medical Inc
3. B. Braun Meslungen AG
4. Stryker
5. Medtronic
6. Smith & Nephew
7. Integra LifeSciences
Table of Contents
260 Pages
- 1. Introduction
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. Global Precision Medicine Market
- 6. Market Share
- 6.1 Product
- 6.2 Technology
- 6.3 Application
- 6.4 End User
- 6.5 Country
- 7. Product
- 7.1 Consumables
- 7.2 Instruments
- 7.3 Services
- 8. Technology
- 8.1 Big Data Analytics
- 8.2 Bioinformatics
- 8.3 Gene Sequencing
- 8.4 Drug Discovery
- 8.5 Companion Diagnostics
- 8.6 Others
- 9. Application
- 9.1 Oncology
- 9.2 Central Nervous System (CNS)
- 9.3 Immunology
- 9.4 Respiratory Medicine
- 9.5 Infections
- 9.6 Others
- 10. End User
- 10.1 Hospitals and Clinics
- 10.2 Diagnostic Centers
- 10.3 Pharma and Biotech Companies
- 10.4 Healthcare IT Firms
- 10.5 Others
- 11. Country
- 11.1 North America
- 11.1.1 United States
- 11.1.2 Canada
- 11.2 Europe
- 11.2.1 France
- 11.2.2 Germany
- 11.2.3 Italy
- 11.2.4 Spain
- 11.2.5 United Kingdom
- 11.2.6 Belgium
- 11.2.7 Netherlands
- 11.2.8 Turkey
- 11.3 Asia Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 Australia
- 11.3.5 South Korea
- 11.3.6 Thailand
- 11.3.7 Malaysia
- 11.3.8 Indonesia
- 11.3.9 New Zealand
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.2 Mexico
- 11.4.3 Argentina
- 11.5 Middle East & Africa
- 11.5.1 South Africa
- 11.5.2 Saudi Arabia
- 11.5.3 UAE
- 12. Porter’s Five Analysis
- 12.1 Bargaining Power of Buyers
- 12.2 Bargaining Power of Suppliers
- 12.3 Degree of Rivalry
- 12.4 Threat of New Entrants
- 12.5 Threat of Substitutes
- 13. SWOT Analysis
- 13.1 Strength
- 13.2 Weakness
- 13.3 Opportunity
- 13.4 Threat
- 14. Key Players Analysis
- 14.1 AstraZeneca plc
- 14.1.1 Overview
- 14.1.2 Recent Development
- 14.1.3 Product Portfolio
- 14.1.4 Financial Insight
- 14.2 Bayer AG
- 14.2.1 Overview
- 14.2.2 Recent Development
- 14.2.3 Product Portfolio
- 14.2.4 Financial Insight
- 14.3 bioMérieux SA
- 14.3.1 Overview
- 14.3.2 Recent Development
- 14.3.3 Product Portfolio
- 14.3.4 Financial Insight
- 14.4 Bristol-Myers Squibb Company
- 14.4.1 Overview
- 14.4.2 Recent Development
- 14.4.3 Product Portfolio
- 14.4.4 Financial Insight
- 14.5 Eli Lilly and Company
- 14.5.1 Overview
- 14.5.2 Recent Development
- 14.5.3 Product Portfolio
- 14.5.4 Financial Insight
- 14.6 F. Hoffmann-La Roche AG
- 14.6.1 Overview
- 14.6.2 Recent Development
- 14.6.3 Product Portfolio
- 14.6.4 Financial Insight
- 14.7 Illumina Inc.
- 14.7.1 Overview
- 14.7.2 Recent Development
- 14.7.3 Product Portfolio
- 14.7.4 Financial Insight
- 14.8 Laboratory Corporation of America Holdings
- 14.8.1 Overview
- 14.8.2 Recent Development
- 14.8.3 Product Portfolio
- 14.8.4 Financial Insight
- 14.9 Merck KGaA
- 14.9.1 Overview
- 14.9.2 Recent Development
- 14.9.3 Product Portfolio
- 14.9.4 Financial Insight
- 14.10 Novartis AG
- 14.10.1 Overview
- 14.10.2 Recent Development
- 14.10.3 Product Portfolio
- 14.10.4 Financial Insight
- 14.11 Pfizer Inc.
- 14.11.1 Overview
- 14.11.2 Recent Development
- 14.11.3 Product Portfolio
- 14.11.4 Financial Insight
- 14.12 Qiagen N.V.
- 14.12.1 Overview
- 14.12.2 Recent Development
- 14.12.3 Product Portfolio
- 14.12.4 Financial Insight
- 14.13 Quest Diagnostics Incorporated
- 14.13.1 Overview
- 14.13.2 Recent Development
- 14.13.3 Product Portfolio
- 14.13.4 Financial Insight
- 14.14 Thermo Fisher Scientific Inc.
- 14.14.1 Overview
- 14.14.2 Recent Development
- 14.14.3 Product Portfolio
- 14.14.4 Financial Insight
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.